AJP - Lung Columbus Instruments
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
 QUICK SEARCH:   [advanced]


     


Am J Physiol Lung Cell Mol Physiol (December 14, 2001). doi:10.1152/ajplung.00421.2000
This Article
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
282/4/L824    most recent
00421.2000v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in Web of Science
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Web of Science (12)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Pan, T.
Right arrow Articles by Mason, R. J
Right arrow Search for Related Content
PubMed
Right arrow Articles by Pan, T.
Right arrow Articles by Mason, R. J

Articles in PresS, published online ahead of print December 14, 2001
Am J Physiol Lung Cell Mol Physiol, 10.1152/ajplung.00421.2000
Submitted on November 22, 2000
Accepted on November 1, 2001

Serum SP-D is a marker of lung injury in rats

Tianli Pan1, Larry D Nielsen1, Martin J Allen1, Kathleen M Shannon2, John M Shannon2, Moises Selmen3, and Robert J Mason4*

1 Department of Medicine, National Jewish Medical and Research Center, Denver, CO, USA
2 Pulmonary Cell Biology, University of Cincinnati, Cincinnati, Cincinnati, OH, USA
3 National Institute of Respiratory Disease, Mexico City, Mexico
4 Department of Medicine, National Jewish Medical and Research Center, Denver, CO, USA; Department of Medicine, University of Colorado Health Sciences Center, Denver, CO, USA

* To whom correspondence should be addressed. E-mail: masonb{at}njc.org.

Pulmonary surfactant protein D (SP-D) is expressed in alveolar type II cells and bronchiolar epithelial cells and is secreted into alveoli and conducting airways. However, SP-D has also been measured in serum and is increased in patients with ARDS, pulmonary fibrosis and alveolar proteinosis. To demonstrate that SP-D could be measured in rat serum, rats were instilled with KGF, which produces type II cell hyperplasia and an increase in SP-D in lavage fluid. To evaluate serum SP-D as a biomarker of lung injury we examined several different injury models. In rats treated with 1 unit of bleomycin, serum SP-D was elevated on days 3, 7, 14, and 28 after instillation, and SP-D mRNA was increased in focal areas as detected by in situ hybridization. However, there was no increase in whole lung SP-D mRNA, when the expression was normalized to whole lung 18S rRNA. After instillation of 2 units of bleomycin, the serum levels of SP-D were higher, and SP-D was also increased in lavage fluid and lung homogenates. In another model of subacute injury serum SP-D was increased in rats treated with paraquat plus oxygen. Finally to evaluate acute lung injury, rats were instilled with HCl and SP-D was increased at 4 hours after instillation. Our data indicate that serum SP-D may be a useful indicator of lung injury and type II cell hyperplasia in rats.




This article has been cited by other articles:


Home page
ThoraxHome page
M D Eisner, P Parsons, M A Matthay, L Ware, and K Greene
Plasma surfactant protein levels and clinical outcomes in patients with acute lung injury
Thorax, November 1, 2003; 58(11): 983 - 988.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
F. Zhang, W. Pao, S. M. Umphress, S. B. Jakowlew, A. M. Meyer, L. D. Dwyer-Nield, L. D. Nielsen, K. Takeda, E. W. Gelfand, J. H. Fisher, et al.
Serum Levels of Surfactant Protein D Are Increased in Mice with Lung Tumors
Cancer Res., September 15, 2003; 63(18): 5889 - 5894.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
Visit Other APS Journals Online
Copyright © 2001 by the American Physiological Society.